Prediction and prevention of the next pandemic zoonosis

The Lancet

Volumn 380, Issue 9857, 2012, Pages 1956-1965

  Morse, Stephen S ^a,c   Mazet, Jonna A K ^c   Woolhouse, Mark ^d   Parrish, Colin R ^e   Carroll, Dennis ^f   Karesh, William B ^g,h   Zambrana Torrelio, Carlos ^g   Lipkin, W Ian ^b   Daszak, Peter ^g  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Animal Health Diagnostic Center   (United States)

^f UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^g ECOHEALTH ALLIANCE   (United States)

^h IUCN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNICATION SOFTWARE; HOST; HUMAN; INFORMATION SCIENCE; MEDICAL RESEARCH; MICROORGANISM; NONHUMAN; PANDEMIC; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ZOONOSIS;

EID: 84870279179     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61684-5     Document Type: Review

References (91)

1. Karesh WB, Dobson A, Lloyd-Smith JO, et al. Ecology of zoonoses: natural and unnatural histories. Lancet 2012: 380: 1936-45.
2. Murphy FA. Emerging zoonoses. Emerg Infect Dis 1998; 4: 429-35. (Pubitemid 28387427)
3. Jones KE, Patel N, Levy M, et al. Global trends in emerging infectious diseases. Nature 2008; 451: 990-94.
4. Lederberg J, Shope RE, Oaks SC. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academies Press, 1992.
5. Keusch GT, Pappaioanou M, Gonzalez MC, Scott KA, Tsai P. Sustaining global surveillance and response to emerging zoonotic diseases. Washington, DC: National Academies Press, 2009.
6. Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis 1995; 1: 7-15.
7. Daszak P, Cunningham AA, Hyatt AD. Emerging infectious diseases of wildlife-threats to biodiversity and human health. Science 2000; 287: 443-49.
8. Keesing F, Belden LK, Daszak P, et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 2010; 468: 647-52.
9. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004; 430: 242-49. (Pubitemid 38902437)
10. Smolinski MS, Hamburg MA, Lederberg J. Microbial threats to health: emergence, detection, and response. Washington, DC: National Academies Press, 2003.
11. Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nat Med 2004; 10: S70-76. (Pubitemid 40018229)
12. Morse SS. Regulating viral traffic. Issues Sci Technol 1990; 7: 81-84.
13. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature 2007; 447: 279-83. (Pubitemid 46788835)
14. Pulliam JRC, Epstein JH, Dushoff J, et al. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J R Soc Interface 2012; 9: 89-101.
15. Goldberg TL, Gillespie TR, Rwego IB, Estoff EL, Chapman CA. Forest fragmentation and bacterial transmission among nonhuman primates, humans and livestock, Uganda. Emerg Infect Dis 2008; 14: 1375-82
16. Mackenzie JS. Emerging viral diseases: an Australian perspective. Emerg Infect Dis 1999; 5: 1-8.
17. Cleaveland S, Laurenson MK, Taylor LH. Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Phil Trans R Soc Lond B 2001; 356: 991-99. (Pubitemid 32696244)
18. Taylor LH, Latham SM, Woolhouse MEJ. Risk factors for human disease emergence. Phil Trans R Soc Lond B 2001; 356: 983-89. (Pubitemid 32696243)
19. Parrish CR, Holmes EC, Morens DM, et al. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Molec Biol Rev 2008; 72: 457-70.
20. Barber MR, Guan Y, Magor KE, Peiris JS, Webster RG. The role of animal surveillance in influenza preparedness: the consequence of inapparent infection in ducks and pigs. Influenza Other Respir Viruses 2011; 5 (suppl 1): 8-11.
21. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-15.
22. Woolhouse MEJ, Gowtage-Sequeria S. Host range and emerging and re-emerging pathogens. Emerg Infect Dis 2005; 11: 1842-47. (Pubitemid 43356078)
23. Kilpatrick AM, Randolph SE. Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet 2012; 380: 1946-55.
24. Woolhouse MEJ, Scott F, Hudson Z, Howey R, Chase-Topping M. Human viruses: discovery and emergence. Phil Trans R Soc B 2012; 367: 2864-71.
25. Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T. Bats: important reservoir hosts of emerging viruses. Clin Microbiol Rev 2006; 19: 531-45. (Pubitemid 44134308)
26. Keele BF, Van Heuverswyn F, Li YY, et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006; 313: 523-26. (Pubitemid 44148457)
27. Li WD, Shi ZL, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310: 676-79. (Pubitemid 41528160)
28. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science 2003; 302: 276-78. (Pubitemid 37248756)
29. Woolhouse MEJ, Taylor LH, Haydon DT. Population biology of multihost pathogens. Science 2001; 292: 1109-12. (Pubitemid 32440923)
30. Liu WM, Li YY, Learn GH, et al. Origin of the human malaria parasite Plasmodium falciparum in gorillas. Nature 2010; 467: 420-25.
31. Anderson RM, Fraser C, Ghani AC, et al. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Phil Trans R Soc Lond B 2004; 359: 1091-105. (Pubitemid 38947034)
32. Hufnagel L, Brockmann D, Geisel T. Forecast and control of epidemics in a globalized world. Proc Natl Acad Sci USA 2004; 101: 15124-29. (Pubitemid 39391729)
33. Hosseini P, Sokolow SH, Vandegrift KJ, Kilpatrick AM, Daszak P. Predictive power of air travel and socio-economic data for early pandemic spread. PLoS One 2010; 5: e12763.
34. Ferguson NM, Cummings DAT, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209-14. (Pubitemid 41294478)
35. Chan J, Holmes A, Rabadan R. Network analysis of global influenza spread. PLoS Comp Biol 2010; 6: e10010005.
36. Damon I. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine 2011; 29 (suppl 4): D54-59.
37. Fenner F. Human monkeypox, a newly discovered human virus disease. In: Morse SS, ed. Emerging viruses. Oxford: Oxford University Press, 1993: 176-83.
38. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Molec Biol Rev 1997; 61: 136-69. (Pubitemid 27283798)
39. Fukuyama S, Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 2011; 23: 481-86.
40. Simini F, Gonzalez MC, Maritan A, Barabasi AL. A universal model for mobility and migration patterns. Nature 2012; 484: 96-100.
41. Janes CR, Corbett KK, Jones JH, Trostle J. Emerging infectious diseases: the role of social sciences. Lancet 2012; 380: 1884-86.
42. Ssematimba A, Hagenaars TJ, de Wit JJ, et al. Avian influenza transmission risks: analysis of biosecurity measures and contact structure in Dutch poultry farming. Prev Vet Med 2012; published online Sept 19. DOI:10.1016/j.prevetmed.2012.09.001.
43. Webby R, Hoffmann E, Webster R. Molecular constraints to interspecies transmission of viral pathogens. Nat Med 2004; 10: S77-81. (Pubitemid 40018230)
44. Davies TJ, Pedersen AB. Phylogeny and geography predict pathogen community similarity in wild primates and humans Proc Roy Soc B 2008; 275: 1695-701. (Pubitemid 351809743)
45. Pepin KM, Lass S, Pulliam JRC, Read AF, Lloyd-Smith JO. Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat Rev Microbiol 2010; 8: 802-13.
46. Lloyd-Smith JO, George D, Pepin KM, et al. Epidemic dynamics at the human-animal interface. Science 2009; 326: 1362-67.
47. Grenfell BT, Pybus OG, Gog JR, et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004; 303: 327-32. (Pubitemid 38095764)
48. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008; 453: 615-19. (Pubitemid 351769300)
49. Holmes EC. The evolution and emergence of RNA viruses. Oxford: Oxford University Press, 2009.
50. Gilbert GS, Webb CO. Phylogenetic signal in plant pathogen-host range. Proc Natl Acad Sci USA 2007; 104: 4979-83. (Pubitemid 47186162)
51. Lipkin WI. Microbe hunting. Microbiol Molec Biol Revs 2010; 74: 363-77.
52. Relman DA. Microbial genomics and infectious diseases. N Engl J Med 2011; 365: 347-57.
53. Morse SS. Toward an evolutionary biology of viruses. In: Morse SS, ed. The evolutionary biology of viruses. New York: Wolters Kluwer/Raven Press, 1994: 1-28.
54. Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol 2010; 84: 3134-46.
55. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT. Host species barriers to influenza virus infections. Science 2006; 312: 394-97.
56. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336: 1541-47.
57. Baric RS, Sims AC. Humanized mice develop coronavirus respiratory disease. Proc Natl Acad Sci USA 2005; 102: 8073-74. (Pubitemid 40800045)
58. Dorner M, Horwitz JA, Robbins JB, et al. A genetically humanized mouse model for hepatitis C virus infection Nature 2011; 474: 208-11.
59. Kalscheuer H, Danzl N, Onoe T, et al. A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med 2012; 4: 125ra30.
60. Downs WG. The Rockefeller Foundation Virus Program: 1951-1971 with update to 1981. Annu Rev Med 1982; 33: 1-29.
61. Wolf B, Morgan H, Krieg J, et al. A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans. Cytokine 2012; 60: 828-37.
62. Vidal JM, Kawabata TT, Thorpe R, et al. In vitro cytokine release assays for predicting cytokine release syndrome: the current state-of-the-science. Report of a European Medicines Agency Workshop. Cytokine 2010; 51: 213-15.
63. Streicker DG, Turmelle AS, Vonhof MJ, Kuzmin IV, McCracken GF, Rupprecht CE. Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science 2010; 329: 676-79.
64. Peiris JSM, Poon LLM, Guan Y. Surveillance of animal influenza for pandemic preparedness. Science 2012; 335: 1173-74.
65. Pulliam JRC. Viral host jumps: moving toward a predictive framework. Ecohealth 2008; 5: 80-91.
66. Pulliam JRC, Dushoff J. Ability to replicate in the cytoplasm predicts zoonotic transmission of livestock viruses. J Infect Dis 2009; 199: 565-68.
67. Burke DS. The evolvability of emerging viruses. In: Nelson AM, Horsburgh CR, eds. Pathology of emerging infections. Washington, DC: American Society for Microbiology, 1998: 1-12.
68. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486: 420-28.
69. Herfst S, Schrauwen EJA, Linster M, et al. Airborne transmission of Influenza A/H5N1 virus between ferrets. Science 2012; 336: 1534-41.
70. Moresco EM, LaVine D, Beutler B. Toll-like receptors. Curr Biol 2011; 21: R488-93.
71. Moresco EM, Beutler B. Resisting viral infection: the gene by gene approach. Curr Opin Virol 2011; 1: 513-18.
72. Ewald PW. Evolution of infectious disease. New York: Oxford University Press, 1996.
73. Wolfe ND, Switzer WM, Carr JK, et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 2004; 363: 932-37. (Pubitemid 38388326)
74. Cui J, Han NIJ, Streicker D, et al. Evolutionary relationships between bat coronaviruses and their hosts. Emerg Infect Dis 2007; 13: 1526-32. (Pubitemid 350010893)
75. Antia R, Regoes RR, Koella JC, Bergstrom CT. The role of evolution in the emergence of infectious diseases. Nature 2003; 426: 658-61. (Pubitemid 38009372)
76. Bull J, Dykhuizen D. Epidemics-in-waiting. Nature 2003; 426: 609-10. (Pubitemid 38009352)
77. Morse SS, Rosenberg BH, Woodall J. ProMED global monitoring of emerging diseases: design for a demonstration program. Health Policy 1996; 38: 135-53. (Pubitemid 26338158)
78. National Biosurveillance Advisory Subcommittee. Improving the nation's ability to detect and respond to 21st century urgent health threats: second report of the National Biosurveillance Advisory Subcommittee. http://www.cdc.gov/about/advisory/pdf/NBASFinalReport-April2011.pdf (accessed Nov 12, 2012).
79. Morse SS. Public health surveillance and infectious disease detection. Biosec Bioterr 2012; 10: 6-16.
80. WHO. Global Outbreak Alert & Response Network. http://www.who.int/ csr/outbreaknetwork/en/ (accessed Sept 25, 2012).
81. Chan EH, Brewer TF, Madoff LC, et al. Global capacity for emerging infectious disease detection. Proc Natl Acad Sci USA 2010; 107: 21701-06.
82. Long WJ. Pandemics and peace: public health cooperation in zones of conflict. Washington, DC: United States Institute of Peace Press, 2011.
83. Kimball AM, Moore M, French HM, et al. Regional infectious disease surveillance networks and their potential to facilitate the implementation of the international health regulations. Med Clin North Am 2008; 92: 1459-71.
84. WHO. International Health Regulations (2005), 2nd ed. Geneva: World Health Organization, 2008.
85. University of California, Davis. PREDICT. http://www.vetmed.ucdavis.edu/ ohi/predict/index.cfm (accessed Nov 12, 2012)
86. Karesh WB, Cook RA. One world-one health. Clin Med 2009; 9: 259-60.
87. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 53: 1374-85. (Pubitemid 41362705)
88. Writing committee of the second WHO consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358: 261-73.
89. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-20.
90. Grard G, Fair JN, Lee D, et al. A novel rhabdovirus associated with acute hemorrhagic fever in central Africa. PLoS Pathog 2012; 8: e1002924.
91. Claas ECJ, Osterhaus ADME, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351: 472-77. (Pubitemid 28070093)